Identification of structurally distinct catalytic intermediates of the H+-ATPase from yeast plasma membranes.
Mild trypsin proteolysis of the H+-ATPase from yeast plasma membranes has been used to identify structurally distinct catalytic intermediates. In the absence of substrate, trypsin treatment resulted in rapid inactivation of enzyme activity. By contrast, trypsin treatment of enzyme in the presence of MgATP or MgATP plus vanadate resulted in enhanced rates of ATP hydrolysis accompanied by protection from extensive inactivation. High concentrations of Pi also induced strong protection from trypsin-induced inactivation, although enhancement of enzyme activity was not observed. Western blot analysis of peptide fragment profiles following tryptic digestion indicated that at least 15 prominent fragments of identical size, ranging from Mr = 12,800 to 48,000, were generated irrespective of digestion conditions. However, fragments from protected enzyme were resistant to further proteolysis, whereas fragments from unprotected enzyme were extensively degraded. These data have been interpreted in terms of a published catalytic reaction pathway (Amory, A., Goffeau, A., McIntosh, D.B., and Boyer, P.D. (1982) J. Biol. Chem. 257, 12509-12516) and are consistent with unprotected and protected enzyme conformations representing E1 and E2 X Pi catalytic intermediates, respectively. Trypsin proteolysis proved an effective tool for evaluating preferred enzyme conformational states and with this approach, it was found that ATPase inhibitors N-ethylmaleimide and fluorescein isothiocyanate locked the enzyme in an E1 conformation. The enhanced rate of ATP hydrolysis by trypsin-treated enzyme was fully coupled to proton transport, and all fragments generated by proteolysis were firmly bound to the membrane. These results, coupled with the fact that initial peptide fragmentation profiles were independent of enzyme conformation, suggest that the different conformational states, E1, and E2 X Pi, are not related to gross changes in overall enzyme structure but likely reflect localized changes in intramolecular bonding.
D002462:Cell Membrane / Q000201:enzymology; D004024:Dicyclohexylcarbodiimide / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D016650:Fluorescein-5-isothiocyanate; D005452:Fluoresceins / Q000494:pharmacology; D007700:Kinetics; D006180:Proton-Translocating ATPases / Q000302:isolation & purification / Q000378:metabolism*; D012441:Saccharomyces cerevisiae / Q000201:enzymology*; D013861:Thiocyanates / Q000494:pharmacology; D014357:Trypsin
D005452:Fluoresceins; D013861:Thiocyanates; D004024:Dicyclohexylcarbodiimide; D014357:Trypsin; D006180:Proton-Translocating ATPases; D016650:Fluorescein-5-isothiocyanate; D005033:Ethylmaleimide